Public Workshop
Adjuvants and Adjuvanted Preventative and Therapeutic Vaccines for Infectious Disease Indications
December 2 – 3, 2008
The Food and Drug Administration (FDA), in cooperation with the National Institutes of Health (NIH), is announcing a workshop on Adjuvants and Adjuvanted vaccines. This is a 2-day workshop for academics, government researchers, government regulators, vaccine clinical trial experts and industry representatives. The purpose of this workshop is to assess the scientific knowledge base regarding vaccine adjuvants and to facilitate the development of a research agenda to improve the safety and efficacy assessments of adjuvanted vaccines for the treatment and prevention of disease.
Printable Version: Workshop Agenda (PDF - 44 KB)
December 2, 2008
Printable Version: Workshop Transcript Day 1 (PDF - 3 MB)
December 3, 2008
Printable Version: Workshop Transcript Day 2 (PDF - 1 MB)
Presentations
Workshop: Adjuvants and Adjuvanted Preventive and Therapeutic Vaccines for Infectious Disease Indications (PDF - 149 KB) - Jesse L. Goodman, MD, MPH
Public Workshop: Adjuvants and Adjuvanted Preventive and Therapeutic Vaccines for Infectious Disease Indications (PDF - 129 KB) - Norman W. Baylor, Ph.D.
Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®.
Location
Bethesda North Marriot and Conference Center
5701 Marinelli Road
Rockville, MD 20852
(800) 859-8003
Registration
To register by email go to: http://www3.niaid.nih.gov/about/organization/dait/adjuvantsWorkshop.htm. (The FDA has verified the Web site address, but is not responsible for subsequent changes to the web site.) Attendees are responsible for their own accommodations. Space is limited; therefore interested parties are encouraged to register early. Limited onsite registration may be available. Please arrive early to ensure prompt registration.
Special Accommodations
If you need special accommodations due to a disability, please contact Nicolette deVore (see contact) at least 21 days in advance of the workshop.
Contact
Nicolette deVore
CBER/FDA
301-496-4861
e-mail: nicolette.devore@fda.hhs.gov